The Leadless Pacemaker Market in 2026 is experiencing its most significant clinical and commercial development milestone in the achievement of true dual-chamber leadless pacing capability through the Abbott Aveir DR system, which uses two independently implanted leadless capsules in the right atrium and right ventricle that communicate wirelessly to achieve coordinated sensing and pacing that...
0 Commentarios
0 Acciones
748 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek